Opal Sandy became the first person to participate in a gene therapy trial, restoring her hearing. The treatment involved a quick surgery with an infusion containing a working copy of the gene.
Results of the trial exceeded expectations, showing the potential to cure patients with auditory neuropathy. The therapy targets the faulty OTOF gene, enabling ear cells to communicate with the hearing nerve.
Collection
[
|
...
]